Diagnosis and Management of Cardiovascular Disease During the COVID-19 Pandemic

Even after two years of the World Health Organization announcing a global COVID-19 pandemic, experts are still trying to understand the respiratory virus’s cascading impact throughout the body. Cardiovascular disease (coronary heart disease, heart attacks, rheumatic heart disease, cardiomyopathies, arrhythmia), cerebrovascular disease, and strokes, as well as cardiovascular risk factors, are associated with significant morbidity and severity in patients with COVID-19 when compared to these comorbid conditions separately.

Hypertension, obesity, and diabetes are risk factors for cardiovascular disease. Non-conventional causes such as stress, anxiety, unhealthy diets, physical inactivity, and narcotic usage, which have reportedly increased during the pandemic, are thought to be causing the surge in heart-related disorders. Furthermore, even individuals between the ages of 20 and 40 who did not have any predisposing cardiovascular risk factors, were at increased risk

MedPiper Technologies and JournoMed in association with Frontier Lifeline Private Limited are conducting a webinar titled “Diagnosis and Management of Cardiovascular Diseases during the COVID-19 pandemic” which will explore the various factors of CVD during the pandemic.

The event will take place on 16th April, Saturday at 6 PM and participants can register in advance for this webinar here. After registering, participants will receive a confirmation email containing information about joining the webinar. For further support please contact at / 9080078447

Expert Speaker: Dr. Anup Charles S

Consultant- Pediatric Cardio Thoracic and Vascular Surgeon

Frontier Lifeline Private Limited

(Dr. K.M. Cherian Heart Foundation)

Some of the tests performed by healthcare practitioners to diagnose heart illness include electrocardiograms, holter monitoring, echocardiograms, stress tests, cardiac catheterization, cardiac CT scan, and cardiac MRI. This webinar will go through all of these diagnostic tests as well as the therapy options for cardiovascular disease.

Because COVID-19 patients with cardiovascular comorbidities have a higher death rate, and the severity of COVID-19 disease corresponds with cardiovascular symptoms, it is essential to study the relationship between COVID-19 and cardiovascular disease. This webinar will also cover fundamental strategies for evaluating and clinically managing cardiovascular disease.

Update: The post event summary of the webinar is available to read here.

Show More

Related Articles

Leave a Reply

Back to top button